TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-03 11:48 am Purchase |
2022-07-01 | 13G | Ovid Therapeutics Inc. OVID |
TAKEDA PHARMACEUTICAL CO LTD | 8,781,996 12.200% |
1,250,000 (+16.60%) |
Filing |